Видео ютуба по тегу Car-T Therapy

052-CAR T-Cell Therapy for Pediatric Central Nervous System
052-CAR T-Cell Therapy for Pediatric Central Nervous System
How CAR T Cell Therapy Eliminated a Patient's Rare Blood Disease and Restored Her Strength
How CAR T Cell Therapy Eliminated a Patient's Rare Blood Disease and Restored Her Strength
From Research to Recovery: CAR T-Cell Therapy for Myeloma Patients
From Research to Recovery: CAR T-Cell Therapy for Myeloma Patients
Re-training Your Immune System to Tackle Cancer: Explaining CAR T-cell Therapy
Re-training Your Immune System to Tackle Cancer: Explaining CAR T-cell Therapy
Optimal ferritin threshold to diagnose IEC-HS following CAR T-cell therapy in R/R myeloma
Optimal ferritin threshold to diagnose IEC-HS following CAR T-cell therapy in R/R myeloma
Lupus Breakthrough 2026: New Treatments and The Science of CAR-T Cell Therapy
Lupus Breakthrough 2026: New Treatments and The Science of CAR-T Cell Therapy
#India’s First #Indigenous CAR-T #Cell #Therapy | A Breakthrough in #Cancer #Treatment
#India’s First #Indigenous CAR-T #Cell #Therapy | A Breakthrough in #Cancer #Treatment
Whole process of the CAR T-cell therapy infusion #cancer #medicine #medical which costs ¥1,200,000
Whole process of the CAR T-cell therapy infusion #cancer #medicine #medical which costs ¥1,200,000
The upcoming EBMT-EHA European CAR T-cell meeting 2026: sharing updates in CAR-T & cellular therapy
The upcoming EBMT-EHA European CAR T-cell meeting 2026: sharing updates in CAR-T & cellular therapy
What is CAR T-cell therapy?
What is CAR T-cell therapy?
The CAR T Option
The CAR T Option
Manali Kamdar, MD, on “Expanding access to CAR T-cell therapy outside academic centers.”
Manali Kamdar, MD, on “Expanding access to CAR T-cell therapy outside academic centers.”
Getting to CAR T: How Patients Can Overcome Access Barriers
Getting to CAR T: How Patients Can Overcome Access Barriers
Coordinating Care After CAR T: Staying Safe and Connected
Coordinating Care After CAR T: Staying Safe and Connected
Bridging Therapy & Lymphodepletion: What to Expect on the CAR T Timeline
Bridging Therapy & Lymphodepletion: What to Expect on the CAR T Timeline
Staying [ACT]IVATED Ahead of Relapse: Improving CAR T Durability in Myeloma
Staying [ACT]IVATED Ahead of Relapse: Improving CAR T Durability in Myeloma
Staying [ACT]IVATED: When to Ask About CAR T in Your Myeloma Journey
Staying [ACT]IVATED: When to Ask About CAR T in Your Myeloma Journey
CAR-T Therapy
CAR-T Therapy
Broadcast Med | New CAR T-Cell Therapy Showing Promise for Relapsed/Refractory AML
Broadcast Med | New CAR T-Cell Therapy Showing Promise for Relapsed/Refractory AML
From Lab to Life: A Cancer Biologist’s Journey in CAR-T Cell Therapy | Paridhi Gupta
From Lab to Life: A Cancer Biologist’s Journey in CAR-T Cell Therapy | Paridhi Gupta
Q&A with Jingyu Zhao: In Vivo CAR T Cell Engineering for More Effective, Affordable Cancer Treatment
Q&A with Jingyu Zhao: In Vivo CAR T Cell Engineering for More Effective, Affordable Cancer Treatment
CD70-targeted CAR T-cells for high-risk myeloma after BCMA CAR-T relapse
CD70-targeted CAR T-cells for high-risk myeloma after BCMA CAR-T relapse
Trending in Gene and Cell Therapy: AstraZeneca CAR-T and more
Trending in Gene and Cell Therapy: AstraZeneca CAR-T and more
CAR-T-терапия при лимфоме маргинальной зоны: как эта новая форма иммунотерапии меняет лечение рака.
CAR-T-терапия при лимфоме маргинальной зоны: как эта новая форма иммунотерапии меняет лечение рака.
𝗕𝗥𝗘𝗬𝗔𝗡𝗭𝗜 𝗙𝗗𝗔 𝗔𝗣𝗣𝗥𝗢𝗩𝗔𝗟 𝟮𝟬𝟮𝟱: 𝗙𝗜𝗥𝗦𝗧 𝗖𝗔𝗥-𝗧 𝗧𝗛𝗘𝗥𝗔𝗣𝗬 𝗙𝗢𝗥 𝗠𝗔𝗥𝗚𝗜𝗡𝗔𝗟 𝗭𝗢𝗡𝗘 𝗟𝗬𝗠𝗣𝗛𝗢𝗠𝗔 𝗘𝗫𝗣𝗟𝗔𝗜𝗡𝗘𝗗
𝗕𝗥𝗘𝗬𝗔𝗡𝗭𝗜 𝗙𝗗𝗔 𝗔𝗣𝗣𝗥𝗢𝗩𝗔𝗟 𝟮𝟬𝟮𝟱: 𝗙𝗜𝗥𝗦𝗧 𝗖𝗔𝗥-𝗧 𝗧𝗛𝗘𝗥𝗔𝗣𝗬 𝗙𝗢𝗥 𝗠𝗔𝗥𝗚𝗜𝗡𝗔𝗟 𝗭𝗢𝗡𝗘 𝗟𝗬𝗠𝗣𝗛𝗢𝗠𝗔 𝗘𝗫𝗣𝗟𝗔𝗜𝗡𝗘𝗗